Skip to main content
Figure 1 | BMC Anesthesiology

Figure 1

From: Drotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysis

Figure 1

Simplified decision analytic model employed. *The individual survival probabilities between 28 days and 30 months were included in the model but are not shown in this figure. A similar tree was used in the bleeding and non-bleeding arms, and for the drotrecogin alfa and placebo arms (not shown). After the 30 months a Markov model was employed (determined by the node M).

Back to article page